A decades-old CIA intelligence report is igniting fresh outrage online, but the full story is far more complicated than the headlines suggest.
A newly surfacedCIA documentsuggests US intelligence once reviewed research that hinted at a possible cancer treatment more than 60 years ago. The document was prepared by the Central Intelligence Agency in February 1951, and although it was officially declassified in 2014, it has only recently gained widespread attention after being shared on social media.
The gap between what the document actually says and how it is being characterised online is significant, and understanding that gap matters enormously for public health.
The document, produced in February 1951, summarises a Soviet scientific paper that examined striking similarities between parasitic worms and cancerous tumours. The report describes how researchers believed both organisms thrived under nearly identical metabolic conditions and accumulated large reserves of glycogen, a form of stored energy. The original paper is accessible directly on theCIA's FOIA Electronic Reading Room.
The CIA routinely monitored foreign science during the Cold War; this was standard intelligence work. The document was quietly declassified in 2014 and has been publicly available on the CIA's own website ever since. It was not secretly 'unlocked' recently. The current viral wave is simply people discovering it for the first time.
That document carries a header that reads plainly: 'This Is Unevaluated Information.' That single line is critical. The agency did not endorse its contents, did not advance its findings, and did not classify it to suppress a cure. American intelligence analysts translated and circulated the paper because it was considered potentially relevant to biomedical and national defence research during the early years of the Cold War.
The Soviet paper was authored by Professor V.V. Alpatov and published inPriroda, Vol. XIX, No. 10, in October 1950, out of Leningrad. Alpatov argued that endoparasites, organisms that live inside a host's body, and malignant tumours shared a metabolic profile unusual enough to suggest a possible biological kinship. Both exhibit anaerobic metabolism and deposit glycogen in their tissues, indicating a similar amphibiotic type of metabolism.
One drug cited in theCIA documentwasMyracyl D, a compound synthesised in 1938 by German chemist H. Mauss. The drug had already shown effectiveness against bilharzia, a parasitic disease caused by blood flukes. According to the Soviet research, it also demonstrated activity against malignant tumours.
Another substance discussed in the report wasGuanozolo, a compound chemically similar to guanine, one of the building blocks of DNA and RNA. In laboratory tests, Guanozolo interfered with the production of nucleic acids, molecules essential for cells because they carry genetic information. The Soviet experiments showed that Guanozolo could suppress nucleic acid production in tumour cells grown in mice.
The research also examined how tumours and parasites reacted to a chemical known as atebrin, which exists in two mirror-image forms known as enantiomers. In most animals studied, the left-rotating version of the compound proved more toxic. But tumour tissues from mice, certain molluscs with left-spiralling shells, and parasitic worms inside frogs were more sensitive to the right-rotating form.
Source: International Business Times UK
